Windlas Biotech Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

WINDLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.7%1-day move

₹777.95

prior close

₹779.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.6+0.1+0.8-0.9+2.7+0.5+0.3+0.8+5.4+6.3+5.1+4.9+12.2—

Up moveDown movePending

AI summary

Windlas Biotech Limited has scheduled its Q4 and FY26 earnings conference call for Friday, May 22, 2026 at 12:30 PM IST. The call will discuss the company's financial performance for the quarter and financial year ended March 31, 2026. Key management participants include Mr. Hitesh Windlass (Managing Director) and Ms. Komal Gupta (CEO and CFO). The company has provided dial-in numbers including international toll-free numbers for Hong Kong, Singapore, UK, and USA. This disclosure is made under SEBI (LODR) Regulation 30 as part of routine compliance requirements.

Likely market impact

This announcement indicates the company will release its Q4 and FY26 financial results shortly, likely before or around May 22, 2026. Investors can participate in the earnings call to gain insights into the company's performance and outlook.